Ascimib — Asciminib 40 mg, 30 product-page.units_short, Everest
100% original product

Ascimib Tablets — Asciminib 40 mg (30 Tabs) Everest

54860₴ 59249₴ -7%

Ascimib 40 mg (Asciminib) is a ground-breaking targeted therapy and the first-in-class STAMP inhibitor (Specifically Targeting the ABL Myristoyl Pocket). It is a generic equivalent to Scemblix. Unlike traditional tyrosine kinase inhibitors (TKIs) that bind to the ATP site, Ascimib binds to the myristoyl pocket, locking the BCR-ABL1 protein into an inactive conformation.

Manufacturer: Everest Pharmaceuticals (Bangladesh). Its unique mechanism allows it to work even when tumors have developed resistance to other treatments.

Key Features:

  • Novel Mechanism: Acts as an allosteric inhibitor ("STAMP"), offering a new way to shut down cancer cell growth.
  • Overcoming Resistance: Highly effective in patients who have failed multiple lines of previous TKI therapy.
  • Selectivity: Designed to target the specific mutant protein, minimizing off-target effects.

Prescribed by hematologists for adult patients with:

  • 🔹 Chronic Myeloid Leukemia (CML): In chronic phase (Ph+ CML-CP) previously treated with two or more tyrosine kinase inhibitors (e.g., imatinib, nilotinib, dasatinib).
  • 🔹 T315I Mutation: Treatment of CML with the T315I mutation (requires different dosing strategies).

Sales Unit: Bottle containing 30 film-coated tablets (40 mg strength).

⚠️ APPLICATION INSTRUCTIONS:

  • Standard Dosage: Typically 80 mg daily (taken as 40 mg twice daily approximately 12 hours apart, or 80 mg once daily, as prescribed).
  • Fasting Requirement: Must be taken on an empty stomach. Avoid food for at least 2 hours before and 1 hour after taking the dose. Food significantly reduces absorption.
  • Administration: Swallow tablets whole with water. Do not chew or crush.
  • Missed Dose: If more than 6 hours have passed (for twice-daily regimen), skip the missed dose. Do not double up.
  • Pregnancy & Breastfeeding: Strictly contraindicated due to potential fetal harm.
  • Hypersensitivity to Asciminib.
  • History of pancreatitis (requires monitoring of pancreatic enzymes).
  • Pediatric patients (safety not established).

Regular blood tests are required. Potential side effects include:

  • 🩸 Hematologic: Thrombocytopenia (low platelets), neutropenia, anemia.
  • 🦴 Musculoskeletal: Pain in muscles, joints, or bones.
  • 🤯 General: Fatigue, headache.
  • 🩺 Labs/Vitals: Elevated pancreatic enzymes (amylase/lipase), liver enzymes, hypertension.
Active ingredient
Manufacturer
Everest
Dosage 40 mg
Dosage form Tablets
Tablets per pack 30
100% original product
Delivery across Ukraine
Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00